ArcelorMittal and Devon Energy rallied, Boeing topped the Dow Jones today as stocks posted a strong start to the month of June.
(Bloomberg) -- Tencent Holdings Ltd. dived as much as 11% Tuesday after an offshoot of China’s official news agency decried the “spiritual opium” and “electronic drugs” of games, prompting the country’s largest corporation to declare the possibility of banning kids under the age of 12 from playing altogether.The twin developments stoked fears Beijing will next set its sights on online entertainment after reining in the e-commerce, ride-hailing and online education industries. Tencent joined riva
Shares of General Electric traded higher on Monday as the industrial giant’s 1-for-8 reverse stock split became effective.
Yahoo Finance’s Ines Ferre reports on the day's trending tickers.
QuantumScape founder and CEO Jagdeep Singh tells Yahoo Finance Live he is confident in hitting key production timelines.
GE's turnaround is gaining traction as key businesses improve while the industrial giant continues to shrink its debt load.
French drugmaker Sanofi said it had made a $3.2 billion offer to buy U.S. biotech company Translate Bio, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race. In a statement that confirmed an exclusive report by Reuters, Sanofi said it would acquire all outstanding shares of Translate Bio for $38.00 per share in cash, representing a total equity value of about $3.2 billion for Translate Bio. "Translate Bio adds an mRNA technology platform and strong capabilities to our research, further advancing our ability to explore the promise of this technology to develop both best-in-class vaccines and therapeutics," Chief Executive Paul Hudson said.
Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral coronavirus vaccine. As of 2:20 p.m. EDT, Vaxart's stock price was up more than 12%. Vaxart's S-only vaccine construct produced higher serum antibodies than its other vaccine candidate, which expresses both S and N proteins, in a non-human primate study.
Hundreds of Chinese companies are listed on U.S. markets. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity. Often dozens of Chinese stocks are among the top performers at any given time, across an array of sectors.
President Biden's job approval bounced back to a level President Obama never regained after his first few months in office.
Many investors are so focused on accumulating wealth that they neglect the second part of the equation.
Memory chip maker Micron Technology Inc on Monday said it would shift how it returns cash to shareholders, buying up more shares when prices are low, fewer when prices are high and instituting a dividend for the first time. This can cause swings in profits - and share prices - at most memory makers. Micron on Monday said it would start adjusting its previously regular share repurchases - which have returned about $4 billion in cash to shareholders since 2018 - to match those cycles, holding back when prices are high so that it can retire more shares for each dollar spent.
August is feared as one of the worst months for the S&P 500 — and for good reason. But investors still find ways to make big money.
In this article, we discuss the 10 best high short interest stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best High Short Interest Stocks to Buy Now. Stocks with high short interest have dominated the headlines in the finance world for a good […]
Stellar earnings are propelling chip makers' shares, which trade cheaply compared with the broader stock market.
Suzanne Somers revealed the key to aging happily on her new Yahoo Life series "Unapologetically Suzanne."
Sanofi said on Tuesday it has made a $3.2 billion offer to buy U.S. biotech company Translate Bio, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race, confirming a Reuters exclusive report. Sanofi said it would acquire all outstanding shares of Translate Bio for $38.00 per share in cash, representing a total equity value of about $3.2 billion for Translate Bio. "Translate Bio adds an mRNA technology platform and strong capabilities to our research, further advancing our ability to explore the promise of this technology to develop both best-in-class vaccines and therapeutics," Sanofi Chief Executive Paul Hudson said in a statement.
On Monday morning, shares of XPO Logistics (NYSE: XPO) opened down more than 40%, but there is no bad news to report. The split became official on Monday, with GXO Logistics (NYSE: GXO), the supply chain business, trading for the first time on its own. GXO has a lot of exposure to fast-growing sectors including e-commerce, while XPO is one of the top less-than-truckload trucking operators with a large freight brokerage operation.
For years, Amazon (NASDAQ: AMZN) has felt like a must-own stock. Amazon stock is fallible, it turns out. The tech giant reported revenue growth of 27% to $113.1 billion, missing the analyst consensus at $115.1 billion.
You might think that any stock handpicked by Warren Buffett and his top investment managers would be held in high regard by most investors. Several stocks in Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) portfolio are either beaten down, have bargain valuations, or both. Here are three underrated Buffett stocks that are smart buys right now.
A second-quarter earnings report reminded investors how difficult it is for independent companies to launch new cancer drugs.